Endocrine-disrupting effects of bisphenol-A, thiamethoxam, and fipronil in hormone-naïve transmen compared to cis-women.
Bisphenol A
Endocrine-disrupting chemicals
Fipronil
Thiamethoxam
Transmen
Transsexuality
Journal
Hormones (Athens, Greece)
ISSN: 2520-8721
Titre abrégé: Hormones (Athens)
Pays: Switzerland
ID NLM: 101142469
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
17
09
2023
accepted:
11
06
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
aheadofprint
Résumé
Current evidence suggests that the etiology of gender dysphoria (GD) is multifactorial: this, however, remains unclear. Endocrine-disrupting chemicals (EDCs) are one of the etiological hypotheses. In this study, we aimed to evaluate the urinary levels of bisphenol A (BPA), thiamethoxam, and fipronil in hormone-naïve transmen compared with case-matched cis-women as well as the relation between sex hormone levels and EDCs. Drug-naïve transmen diagnosed with GD and who were referred from the psychiatry outpatient clinic to the outpatient clinic of the Department of Endocrinology, Marmara University Hospital, were included in the study. These individuals were assessed for eligibility; 38 drug-naïve transmen and 22 cis-women were recruited as the control group. After anthropometric evaluation laboratory tests for FSH, LH, total testosterone, and estradiol were carried out, spot urine samples were collected to evaluate the urine metabolic excretion of BPA, thiamethoxam, and fipronil. We found that androgens, total testosterone, androstenedione, and DHEAS levels were significantly higher in transmen than in cis-women. Thiamethoxam was considerably higher in cis-women than in transmen, whereas fipronil and BPA levels were similar in both groups. A negative correlation was found between thiamethoxam and testosterone and between thiamethoxam and BPA levels. The available data suggest that the EDCs that we are most exposed to in our lives are not the only factor in GD development. Even transmen who have not taken hormone replacement have high testosterone levels; however, the mechanism has not as yet been elucidated. The challenge is to determine whether this is a factor leading to GD or a condition that develops in common with GD.
Sections du résumé
BACKGROUND
BACKGROUND
Current evidence suggests that the etiology of gender dysphoria (GD) is multifactorial: this, however, remains unclear. Endocrine-disrupting chemicals (EDCs) are one of the etiological hypotheses.
OBJECTIVES
OBJECTIVE
In this study, we aimed to evaluate the urinary levels of bisphenol A (BPA), thiamethoxam, and fipronil in hormone-naïve transmen compared with case-matched cis-women as well as the relation between sex hormone levels and EDCs.
METHODS
METHODS
Drug-naïve transmen diagnosed with GD and who were referred from the psychiatry outpatient clinic to the outpatient clinic of the Department of Endocrinology, Marmara University Hospital, were included in the study. These individuals were assessed for eligibility; 38 drug-naïve transmen and 22 cis-women were recruited as the control group. After anthropometric evaluation laboratory tests for FSH, LH, total testosterone, and estradiol were carried out, spot urine samples were collected to evaluate the urine metabolic excretion of BPA, thiamethoxam, and fipronil.
RESULTS
RESULTS
We found that androgens, total testosterone, androstenedione, and DHEAS levels were significantly higher in transmen than in cis-women. Thiamethoxam was considerably higher in cis-women than in transmen, whereas fipronil and BPA levels were similar in both groups. A negative correlation was found between thiamethoxam and testosterone and between thiamethoxam and BPA levels.
CONCLUSION
CONCLUSIONS
The available data suggest that the EDCs that we are most exposed to in our lives are not the only factor in GD development. Even transmen who have not taken hormone replacement have high testosterone levels; however, the mechanism has not as yet been elucidated. The challenge is to determine whether this is a factor leading to GD or a condition that develops in common with GD.
Identifiants
pubmed: 38990460
doi: 10.1007/s42000-024-00574-7
pii: 10.1007/s42000-024-00574-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Hellenic Endocrine Society.
Références
Arlington, VA. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Association. https://doi.org/10.1176/apply.books.9780890425596.744053
doi: 10.1176/apply.books.9780890425596.744053
Arcelus J, Bouman WP, Van Den Noortgate W, Claes L, Witcomb G, Fernandez-Aranda F (2015) Systematic review and meta-analysis of prevalence studies in transsexualism. Eur Psychiatry 30(6):807–815. https://doi.org/10.1016/j.eurpsy.2015.04.005
doi: 10.1016/j.eurpsy.2015.04.005
pubmed: 26021270
Saleem F, Rizvi SW (2017) Transgender associations and possible etiology: A literature review. Cureus 24(12):e1984. https://doi.org/10.7759/cureus.1984
doi: 10.7759/cureus.1984
Kerlin S (2005) Prenatal exposure to diethylstilbestrol (DES) in males and gender-related disorders: Results from a 5-year study. Int Behav Dev Symp:1–15
Swan SH, Liu F, Hines M, Kruse RL, Wang C, Redmon JB, Sparks A, Weiss B (2010) Prenatal phthalate exposure and reduced masculine play in boys. Int J Androl 33(2):259–269. https://doi.org/10.1111/j.1365-2605.2009.01019.x
doi: 10.1111/j.1365-2605.2009.01019.x
pubmed: 19919614
Bejerot S, Humble MB, Gardner A (2011) Endocrine disruptors, the increase of autism spectrum disorder and its comorbidity with gender identity disorder--A hypothetical association. Int J Androl 34(5 Pt 2):e350. https://doi.org/10.1111/j.1365-2605.2011.01149.x
doi: 10.1111/j.1365-2605.2011.01149.x
pubmed: 21950370
Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, vd Poll N, Koppe JG, Boer K (1999) Prenatal exposure to anticonvulsants and psychosexual development. Arch Sex Behav 28(1):31–44. https://doi.org/10.1023/a:1018789521375
doi: 10.1023/a:1018789521375
pubmed: 10097803
Konieczna A, Rachoń D, Owczarek K, Kubica P, Kowalewska A, Kudłak B, Wasik A, Namieśnik J (2018) Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome. Reprod Toxicol 82:32–37. https://doi.org/10.1016/j.reprotox.2018.09.006
doi: 10.1016/j.reprotox.2018.09.006
pubmed: 30266220
Baba T, Endo T, Honnma H, Kitajima Y, Hayashi T, Ikeda H, Masumori N, Kamiya H, Moriwaka O, Saito T (2007) Association between polycystic ovary syndrome and female-to-male transsexuality. Hum Reprod 22(4):1011–1016. https://doi.org/10.1093/humrep/del474
doi: 10.1093/humrep/del474
pubmed: 17166864
Combarnous Y (2017) Endocrine Disruptor Compounds (EDCs) and agriculture: The case of pesticides. C R Biol 340(9-10):406–409. https://doi.org/10.1016/j.crvi.2017.07.009
doi: 10.1016/j.crvi.2017.07.009
pubmed: 28826788
Dinçay O, Civelek HS (2017) Determination of insecticide residues in citrus ecosystems of Ortaca–Muğla region. Turkish Bull Entomol 7:31–40. https://doi.org/10.16969/teb.94770
doi: 10.16969/teb.94770
Tüzer E, Muz MN, Bilgin Z, Erçin S, Tinar R (2010) Efficacy of fipronil spot on against fleas on cats and dogs and ticks on dogs. J Fac Vet Med University of Kafkas, Kars, Turkey 16:469–472. https://doi.org/10.9775/kvfd.2009.1044
doi: 10.9775/kvfd.2009.1044
Gea M, Zhang C, Tota R, Gilardi G, Di Nardo GD, Schilirò T (2022) Assessment of five pesticides as endocrine-disrupting chemicals: Effects on estrogen receptors and aromatase. Int J Environ Res Public Health 19(4):1959. https://doi.org/10.3390/ijerph19041959
doi: 10.3390/ijerph19041959
pubmed: 35206146
pmcid: 8871760
Okazaki H, Kohro-Ikeda E, Takeda S, Ishii H, Furuta E, Matsuo S, Matsumoto M, Takiguchi M, Aramaki H (2016) Fipronil, an insecticide, acts as an antiestrogen via the concomitant down-regulation of ERα and PES1. Fundam Toxicol Sci 3:33–37. https://doi.org/10.2131/fts.3.33
doi: 10.2131/fts.3.33
Hughes IA, Houk C, Ahmed SF, Lee PA, Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology Consensus Group (2006) Consensus statement on management of intersex disorders. J Pediatr Urol 2:148–162. https://doi.org/10.1016/j.jpurol.2006.03.004
doi: 10.1016/j.jpurol.2006.03.004
pubmed: 18947601
Mueller A, Gooren LJ, Naton-Schötz S, Cupisti S, Beckmann MW, Dittrich R (2008) Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals. J Clin Endocrinol Metab 93(4):1408–1411. https://doi.org/10.1210/jc.2007-2808
doi: 10.1210/jc.2007-2808
pubmed: 18211977
Erel P, Elbasan O, Yorguner N, İmre E, Üstay Ö (2023) Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study. Endokrynol Pol 14. https://doi.org/10.5603/EP.a2023.0052
Dessens AB, Slijper FME, Drop SLS (2005) Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 34(4):389–397. https://doi.org/10.1007/s10508-005-4338-5
doi: 10.1007/s10508-005-4338-5
pubmed: 16010462
Nordenström A, Servin A, Bohlin G, Larsson A, Wedell A (2002) Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 87(11):5119–5124. https://doi.org/10.1210/jc.2001-011531
doi: 10.1210/jc.2001-011531
pubmed: 12414881
Bao AM, Swaab DF (2011) Sexual differentiation of the human brain: Relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol 32(2):214–226. https://doi.org/10.1016/j.yfrne.2011.02.007
doi: 10.1016/j.yfrne.2011.02.007
pubmed: 21334362
Kawa IA, Masood A, Fatima Q, Mir SA, Jeelani H, Manzoor S, Rashid F (2021) Endocrine disrupting chemical bisphenol A and its potential effects on female health. Diabetes Metab Syndr Clin Res Rev 15(3):803–811. https://doi.org/10.1016/j.dsx.2021.03.031
doi: 10.1016/j.dsx.2021.03.031
Pollock T, Arbuckle TE, Guth M, Bouchard MF, St-Amand A (2021) Associations among urinary triclosan and bisphenol A concentrations and serum sex steroid hormone measures in the Canadian and U.S. Populations. Environ Int 146:106229. https://doi.org/10.1016/j.envint.2020.106229
doi: 10.1016/j.envint.2020.106229
pubmed: 33161203
Gounden V, Warasally MZ, Magwai T, Naidoo R, Chuturgoon A (2021) A pilot study: Relationship between bisphenol A, bisphenol A glucuronide and sex steroid hormone levels in cord blood in A South African population. Reprod Toxicol 100:83–89. https://doi.org/10.1016/j.reprotox.2021.01.004
doi: 10.1016/j.reprotox.2021.01.004
pubmed: 33453334
Patisaul HB (2017) Endocrine disruption by dietary phyto-oestrogens: Impact on dimorphic sexual systems and behaviours. Proc Nutr Soc 76(2):130–144. https://doi.org/10.1017/S0029665116000677
doi: 10.1017/S0029665116000677
pubmed: 27389644
Arambula SE, Fuchs J, Cao J, Patisaul HB (2017) Effects of perinatal bisphenol A exposure on the volume of sexually dimorphic nuclei of juvenile rats: A CLARITY-BPA consortium study. Neurotoxicology 63:33–42. https://doi.org/10.1016/j.neuro.2017.09.002
doi: 10.1016/j.neuro.2017.09.002
pubmed: 28890130
pmcid: 5683931
Patisaul HB, Fortino AE, Polston EK (2006) Neonatal genistein or bisphenol-A exposure alters sexual differentiation of the AVPV. Neurotoxicol Teratol 28(1):111–118. https://doi.org/10.1016/j.ntt.2005.11.004
doi: 10.1016/j.ntt.2005.11.004
pubmed: 16427766
McCaffrey KA, Jones B, Mabrey N, Weiss B, Swan SH, Patisaul HB (2013) Sex specific impact of perinatal bisphenol A (BPA) exposure over a range of orally administered doses on rat hypothalamic sexual differentiation. Neurotoxicology 36:55–62. https://doi.org/10.1016/j.neuro.2013.03.001
doi: 10.1016/j.neuro.2013.03.001
pubmed: 23500335
pmcid: 3771380
Gioiosa L, Parmigiani S, Vom Saal FS, Palanza P (2013) Effects of bisphenol A on emotional behavior depend upon timing of exposure, age at testing and gender in mice. Horm Behav 63(4):598–605. https://doi.org/10.1016/j.yhbeh.2013.02.016
doi: 10.1016/j.yhbeh.2013.02.016
pubmed: 23470777
Farabollini F, Porrini S, Della Seta DD, Bianchi F, Dessì-Fulgheri F (2002) Effects of perinatal exposure to bisphenol A on sociosexual behavior of female and male rats. Environ Health Perspect 110(Suppl 3):409–414. https://doi.org/10.1289/ehp.02110s3409
doi: 10.1289/ehp.02110s3409
pubmed: 12060837
pmcid: 1241191
Yamamuro M, Komuro T, Kamiya H, Kato T, Hasegawa H, Kameda Y (2019) Neonicotinoids disrupt aquatic food webs and decrease fishery yields. Science 366(6465):620–623. https://doi.org/10.1126/science.aax3442
doi: 10.1126/science.aax3442
pubmed: 31672894
Kara M, Yumrutas O, Demir CF, Ozdemir HH, Bozgeyik I, Coskun S, Eraslan E, Bal R (2015) Insecticide Imidacloprid influences cognitive functions and alters learning performance and related gene expression in a rat model. Int J Exp Pathol 96:332–337. https://doi.org/10.1111/iep.12139
doi: 10.1111/iep.12139
pubmed: 26568164
pmcid: 4693560
Takada T, Yoneda N, Hirano T, Yanai S, Yamamoto A, Mantani Y, Yokoyama T, Kitagawa H, Tabuchi Y, Hoshi N (2018) Verification of the causal relationship between subchronic exposures to dinotefuran and depression-related phenotype in juvenile mice. J. Vet Med Sci 80:720–724. https://doi.org/10.1292/jvms.18-0022
doi: 10.1292/jvms.18-0022
Bal R, Türk G, Tuzcu M, Yılmaz Ö, Kuloğlu T, Baydaş G, Naziroğlu M, Yener Z, Etem E, Tuzcu Z (2013) Effects of the neonicotinoid insecticide, clothianidin, on the reproductive organ system in adult male rats. Drug Chem Toxicol 36:421–429. https://doi.org/10.3109/01480545.2013.776575
doi: 10.3109/01480545.2013.776575
pubmed: 23527526
Kapoor U, Srivastava MK, Srivastava LP (2011) Toxicological impact of technical Imidacloprid on ovarian morphology, hormones and antioxidant enzymes in female rats. Food Chem Toxicol 49:3086–3089. https://doi.org/10.1016/j.fct.2011.09.009
doi: 10.1016/j.fct.2011.09.009
pubmed: 21946071
Caron-Beaudoin E, Viau R, Hudon-Thibeault AA, Vaillancourt C, Sanderson JT (2017) The use of a unique co-culture model of fetoplacental steroidogenesis as a screening tool for endocrine disruptors: The effects of neonicotinoids on aromatase activity and hormone production. Toxicol Appl Pharmacol 1(332):15–24. https://doi.org/10.1016/j.taap.2017.07.018
doi: 10.1016/j.taap.2017.07.018
Xu M, Zhang Z, Li Z, Kan S, Liu Z, Wang D, Liu Q, Zhang H (2021) Profiles of neonicotinoid insecticides and characteristic metabolites in paired urine and blood samples: Partitioning between urine and blood and implications for human exposure. Sci Total Environ 773:145582. https://doi.org/10.1016/j.scitotenv.2021.145582
doi: 10.1016/j.scitotenv.2021.145582
pubmed: 33582343
Yue M, Liu Q, Wang F et al (2022) Urinary neonicotinoid concentrations and pubertal development in Chinese adolescents: A cross-sectional study. Environ Int 163:107186. https://doi.org/10.1016/j.envint.2022.107186
doi: 10.1016/j.envint.2022.107186
pubmed: 35325769
Ohi M, Dalsenter PR, Andrade AJ, Nascimento AJ (2004) Reproductive adverse effects of fipronil in Wistar rats. Toxicol Lett Jan 15(146):121–127. https://doi.org/10.1016/j.toxlet.2003.08.008
doi: 10.1016/j.toxlet.2003.08.008
de Barros AL, Rosa JL, Cavariani MM, Borges CS, Villela e Silva P, Bae JH, Anselmo-Franci JA, Cristina Arena A (2016) In utero and lactational exposure to fipronil in female rats: Pregnancy outcomes and sexual development. J Toxicol Environ Health A 79(6):266–273. https://doi.org/10.1080/15287394.2016.1149132
doi: 10.1080/15287394.2016.1149132
pubmed: 27074097